1956
DOI: 10.1084/jem.104.4.525
|View full text |Cite
|
Sign up to set email alerts
|

Hormonal Influences on Mammary Tumors of the Rat

Abstract: PLATES 43 ~O 45(Received for publication, June 21, 1956) This paper is concerned with conditions required for the growth of a transplanted benign m a m m a r y tumor of the rat and with the identification of hormones which accelerate its growth in animals deprived of the ovaries and the hypophysis. The mammary glands of these rats are atrophic y e t grow in the presence of certain hormones and so permit the study in parallel of the growth of the tumor and of the breast of its host. Do these closely related … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
7
0

Year Published

1957
1957
2012
2012

Publication Types

Select...
5
4

Relationship

3
6

Authors

Journals

citations
Cited by 32 publications
(8 citation statements)
references
References 14 publications
1
7
0
Order By: Relevance
“…The benign mammary fibroadenoma studied in the present work grows to a considerable size within 50 days in normal adult female rats whereas its growth is slight after the ovaries have been removed; the retarding effect of ovariectomy upon the growth of a similar tumor has been described earlier (2). The growth of the tumor is enhanced profoundly in ovariectomized rats by the administration of phenolic estrogens in critical quantities, or progesterone (1). In hypophysectomized rats (1) the tumor grows indolently but after some weeks active growth commences despite the absence of growth-promoting hormones as determined by absence of growth in the atrophic tissues of the host--a sensitive biological test.…”
Section: (From the Ben May Laboratory For Cancer Research Of The Univsupporting
confidence: 66%
“…The benign mammary fibroadenoma studied in the present work grows to a considerable size within 50 days in normal adult female rats whereas its growth is slight after the ovaries have been removed; the retarding effect of ovariectomy upon the growth of a similar tumor has been described earlier (2). The growth of the tumor is enhanced profoundly in ovariectomized rats by the administration of phenolic estrogens in critical quantities, or progesterone (1). In hypophysectomized rats (1) the tumor grows indolently but after some weeks active growth commences despite the absence of growth-promoting hormones as determined by absence of growth in the atrophic tissues of the host--a sensitive biological test.…”
Section: (From the Ben May Laboratory For Cancer Research Of The Univsupporting
confidence: 66%
“…in the two groups but the content of alkaline phosphatase was considerably lower in the mammary glands of the carcinogen-fed rats. A consequence of ovariectomy in the rat is a decreased content of alkaline phosphatase in the mammary glands accompanied by atrophy of epithelium (23). In the carcinogen-treated rats alkaline phosphatase content of the breast was decreased but the mammary epithelium was not atrophic; to the contrary, a moderately increased epithelial proliferation was present (Fig.…”
Section: Influence Of Hormonal Status On the Development Of Mammary Cmentioning
confidence: 91%
“…Alternatively, naltrexone may indirectly decrease oestrogen or progesterone levels. Research has shown that the growth of transplanted mammary fibroadenomas is retarded by ovariectomy in rats, with the effect strengthened when combined with an adrenalectomy [50]. Similarly in ovarectomised rats, the growth of tumours could be stimulated using phenolic oestrogens, and even more so when combined with progesterone [50].…”
Section: Discussionmentioning
confidence: 99%
“…Research has shown that the growth of transplanted mammary fibroadenomas is retarded by ovariectomy in rats, with the effect strengthened when combined with an adrenalectomy [50]. Similarly in ovarectomised rats, the growth of tumours could be stimulated using phenolic oestrogens, and even more so when combined with progesterone [50]. Abou-Issa and Tejwani found that DMBA induced tumours that responded to naltrexone had both estrogen and progesterone receptors while unresponsive tumours were negative for both receptor types [49].…”
Section: Discussionmentioning
confidence: 99%